CVS Health Corporation
CVS
$65.93
$1.091.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 96.96B | 94.88B | 90.84B | 87.98B | 93.55B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 96.96B | 94.88B | 90.84B | 87.98B | 93.55B |
| Cost of Revenue | 84.81B | 82.87B | 77.85B | 75.88B | 79.94B |
| Gross Profit | 12.14B | 12.01B | 12.99B | 12.11B | 13.61B |
| SG&A Expenses | 10.25B | 10.52B | 10.24B | 10.23B | 10.17B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.06B | 93.39B | 88.09B | 86.11B | 90.11B |
| Operating Income | 1.90B | 1.49B | 2.75B | 1.88B | 3.44B |
| Income Before Tax | 2.13B | 105.00M | 2.34B | 1.58B | 2.71B |
| Income Tax Expenses | 503.00M | 34.00M | 569.00M | 456.00M | 658.00M |
| Earnings from Continuing Operations | 1.62B | 71.00M | 1.77B | 1.12B | 2.05B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 21.00M | 16.00M | 2.00M | -11.00M | -1.00M |
| Net Income | 1.64B | 87.00M | 1.77B | 1.11B | 2.05B |
| EBIT | 1.90B | 1.49B | 2.75B | 1.88B | 3.44B |
| EBITDA | 3.04B | 2.65B | 3.90B | 3.02B | 4.57B |
| EPS Basic | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 |
| Normalized Basic EPS | 0.92 | 0.67 | 1.22 | 0.80 | 1.43 |
| EPS Diluted | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 |
| Normalized Diluted EPS | 0.92 | 0.67 | 1.21 | 0.80 | 1.42 |
| Average Basic Shares Outstanding | 1.26B | 1.26B | 1.26B | 1.26B | 1.29B |
| Average Diluted Shares Outstanding | 1.26B | 1.26B | 1.26B | 1.27B | 1.29B |
| Dividend Per Share | 0.67 | 0.67 | 0.67 | 0.67 | 0.61 |
| Payout Ratio | 50.97% | 962.07% | 48.47% | 75.47% | 38.07% |
